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Abstract – The synthesis of benzo[a]phenoxazinium chlorides which are 
bifunctionalised in position 2 with 4-ethoxy-4-oxobutoxyl, 3-hydroxypropoxyl or 3-
chloropropoxyl groups, and in position 9 with the (aminopropyl)amino group, was 
efficiently performed. The covalent labeling of valine was carried out by using one of 
the new fluorophores obtained.  Photophysical studies in the homogeneous media of 
ethanol, distilled water and at simulated physiological conditions revealed that all the 
compounds absorbed and emitted from 610 to 651 nm. 
____________________________________________________________________________ 
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Detection based on the fluorescence ability of several compounds is an effective tool for 
the visualization and quantification of non- or weak fluorescent analytes due to its high 
sensitivity and simplicity.
1–3
 In the case of biomolecules, the fluorescent detection of 
nucleic acids, peptides and proteins is frequently used in cell biology, biochemistry, 
proteomics, immunochemistry, flow cytometry and medical diagnostics.
4-10
  
As peptides and proteins contain a broad variety of nucleophilic functional groups, 
namely thiols, carboxylic acids, amines, imidazole residues, phenolic and aliphatic 
hydroxyls, covalent labeling is frequently carried out by modifying a cysteine residue 
with appropriate thiol-reactive probes or through the reaction of their other groups with 
specific reagents.
11-14
 Among the fluorophores used for protein and peptide labeling are 
coumarins, quinolones, chromones, fluoresceins, rhodamines, cyanines and 
benzophenoxazines.
15-21
  
In order to avoid a possible interference with the measurement of the label fluorescence, 
which could happen in many biological samples and usually occurs in the blue or green 
regions of the spectrum, one should improve the sensitivity of detection in the case of 
 3 
studies with biomolecules by using compounds with emission in the red or near-
infrared. 
1-3,21 
 
Fluorescent derivatization has been considered to be one of the most sensitive methods 
for the determination of analytes at low concentrations. As a result, significant efforts 
have been directed at the development of new fluorescent labeling reagents or the 
modification of known fluorophores. Research in long-wavelength fluorophores 
continues to be relevant for biological purposes in order to obtain compounds with 
improved water solubility, functional groups, and enhanced fluorescence quantum 
efficiency, which tends to decrease dramatically with increasing emission wavelengths.  
Bearing all these facts in mind, and as a continuation of our previous research,
22-25
 the 
present work describes the synthesis of new benzo[a]phenoxazine derivatives 
possessing two functional groups, namely carboxylic ester, hydroxyl and the chlorine 
atom, in addition to the amine function. As a result, these compounds are capable of 
covalent linkage to bio(molecules), and can also connect to another entity. As a 
preliminary study, 3-amino-N-(2-(4-ethoxy-4-oxobutoxy)-5-(propylamino)-9H-
benzo[a]phenoxazin-9-ylidene)propan-1-aminium chloride 4b was efficiently used in 
the derivatisation of L-valine at its carboxylic group. Evaluation of absorption and 
emission properties of all benzo[a]phenoxazines and the conjugate synthesised was 
performed in ethanol, at physiological pH and distilled water.  
 
Alkylation of the hydroxyl group of 5-(propylamino)naphthalen-2-ol 1a
26
 with ethyl 4-
bromobutanoate, 3-bromopropan-1-ol and 1-bromo-3-chloropropane, using cesium 
carbonate as a base, by heating at 60ºC in acetonitrile, gave ethyl 4-((5-
(propylamino)naphthalen-2-yl)oxy)butanoate 1b, 3-((5-(propylamino)naphthalen-2-
yl)oxy)propan-1-ol 1c and 6-(3-chloropropoxy)-N-propylnaphthalen-1-amine 1d, 
respectively.
27 
Starting from 3-aminophenol and using 3-bromopropan-1-amine in 
ethanol under reflux conditions yielded 3-((3-aminopropyl)amino)phenol hydrobromide 
2.
28
 After column chromatography purification or isolation by filtration from the 
reaction mixture (2), compounds 1b-d and 2 were obtained as an oil (1b, 97%) or solids 
(1c, 96%; 1d, 93%; 2, 98%), and were characterised by high resolution mass 
spectrometry, IR and NMR (
1
H and 
13
C) spectroscopy. Compound 2 was further reacted 
with sodium nitrite in an acid solution to give 5-((3-aminopropyl)amino)-2-
nitrosophenol di-hydrochloride 3.
 29,30
 
 4 
Condensation of precursors 1a-d with the nitrosophenol 3, in the presence of 
hydrochloric acid, produced the target benzo[a]phenoxazinium chlorides 4a-d (Scheme 
1).
31
 Through purification by several washings with dichloromethane and mixtures of 
dichloromethane/methanol, these functionalised heterocycles were isolated as solids or 
an oily solid (4b) in good to excellent yields, and were fully characterised by the usual 
analytical techniques.  
The covalent labelling of biomolecules with monofunctionalised 
benzo[a]phenoxazinium chlorides by the amine, or a terminal functional group of the 
substituent in 5-position of the tetracyclic fluorophore, was previously investigated by 
the authors.
23,32
 As a continuation of these studies, the present work also aims to 
investigate, for the first time, the possibility of using the 9-position, namely the terminal 
amino group, in the derivatisation of analytes. Thus, compound 4b was bonded to the C-
terminus of N-tert-butyloxycarbonyl-L-valine, as a simple model of biomolecules, by 
using N,N’-dicyclohexylcarbodiimide (DCC) and 1-hydroxybenzotriazole (HOBt), 
under standard conditions (Scheme 1),
33
 yielding the expected conjugate 5, after 
purification by column chromatography. 
 
<Scheme 1> 
 
1
H NMR spectra of compounds 4a-d and 5 showed signals of the aliphatic protons from 
the methylene and methyl groups (δ 1.03 to 4.30 ppm) of the substituents of positions 5 
and 9, as well as the expected aromatic protons such as H-8 (δ 6.50-6.75 ppm), and H-6 
(δ 6.47-6.80 ppm). In the case of conjugate 5, protons corresponding to the valine 
residue appeared namely -CH (δ 3.80-3.92 ppm), -CH (δ 2.0-2.12 ppm), -CH3 (δ 
0.80-1.10 ppm), and the methyls of the N-tert-butyloxycarbonyl protecting group (δ 
1.47 ppm). 
13
C NMR spectra of these compounds showed signals of the aliphatic carbons from the 
methylene and methyl groups (δ 11.72 to 68.78 ppm) of the substituents of positions 5 
and 9, as well as the expected aromatic signals such as C-8 (δ 93.47-95.30 ppm) and C-
6 (δ 92.94-95.53 ppm). In the conjugate 5, carbons corresponding to the valine residue 
were observed, namely -CH (δ 62.18 ppm), -CH (δ 31.56 ppm), -CH3 (δ 18.70 
ppm), as well as the C(CH3)3 of the N-tert-butyloxycarbonyl protecting group (CH3, 
28.84 ppm;  C(CH3)3, 80.61 ppm). The signals of the carbonyl groups of ester (4b, 5; δ 
 5 
 174.90 ppm), urethane (5, δ 157.74 ppm) and amide (5, δ 165.26 ppm) type were also 
shown in the spectra. 
Electronic absorption studies of 10
– 6 
or 10
– 5
M solutions of fluorophores 4a-d and 
conjugate 5 in degassed absolute ethanol, simulated physiological conditions (pH 7.4
34
) 
and distilled water were carried out (Table 1).  
These compounds showed maximum absorption (λabs) in all the solvents studied at long 
wavelengths, namely in the range 610-625 nm. Considering the influence of the solvent 
in the values of abs, it was found that from ethanol to aqueous solutions of distilled 
water and pH 7.4, there was a hipsochromic shift between 2 and 10 nm (4b, in water). 
The structural alterations relating to the ether substituents in the aromatic ring (4b-d) 
resulted in a bathochromic shift (with the exception of 4b at pH 7.4 and distilled water), 
more notably the shift of 7 and 12 nm in 4b and 5, regarding 4a in ethanol. It is also 
stressed the hipsochromic shift of 5 nm of 4b in comparison with 4d in distilled water. 
Additionally, the linkage of 4b to valine resulted in a bathochromic shift in all solvents 
studied, which was higher in distilled water (8 nm).  
 
<Table 1> 
 
Furthermore, it was found that in ethanol and distilled water only compounds 4a and 4c 
showed aggregation, a trend that was less evident in water for both compounds (Figure 
1). At pH 7.4, 4a and 4c continued to form H-aggregates, and the behavior of 4d is 
identical to that for ethanol, with only a slight tendency for aggregation. Compound 4a 
showed the largest aggregation, the maximum absorption value for the band 
corresponding to the monomer was only slightly higher than that of the dimmer (Figure 
2). In order to further investigate the concentration dependence, absorption spectra of 
these compounds in ethanol, distilled water and at pH 7.4 were run in concentrations 
between 2.0×10
–6 
to 3.0×10
–5
M. It was found that in this range of concentrations, no 
significant variations in the dimerization occurred. 
 
< Figure 1> 
< Figure 2> 
 
The evaluation of the fluorescence properties of benzo[a]phenoxazines 4a-d and 
conjugate 5 in the UV/Vis/NIR using Oxazine 1 as a standard (relative fluorescence 
 6 
quantum yield, ΦF = 0.11 in ethanol
35
) was also performed using the same solvents as in 
the studies of absorbance, i.e., ethanol, aqueous solution at pH 7.4 and distilled water. 
The wavelengths of maximum emission, the Stokes’ shifts, as well as the relative 
fluorescence quantum yields for all compounds were obtained and are presented in 
Table 1. All compounds were excited at 590 nm and displayed wavelengths of 
maximum emission (em) between 641 and 651 nm (Figure 3). By comparing the values 
of λem in ethanol and aqueous solutions, it was found that a slight bathochromic shift 
occurred for all compounds, the highest value being that of compound 4a at pH 7.4 (10 
nm). As in the case of abs, conjugate 5 displayed a bathochromic shift in em, in all 
solvents, which was higher in distilled water (8 nm), when compared to the fluorophore 
precursor 4b. 
Regarding the Stokes’ shift, all benzo[a]phenoxazinium chlorides showed the highest 
values in aqueous solutions (32-38 nm). The relative fluorescent quantum yields were 
located in the range 0.26 to 0.88; the best values were found in solutions of distilled 
water for compounds O-substituted 4b-d, including conjugate 5 (showing the same 
value in ethanol). According to these data, it appears that ΦF values are sensitive to pH, 
so compounds 4a-d were investigated in aqueous solution of pH 3, 5, 8, 10 and 12 using 
appropriate buffer solutions
34
 (C = 3.0×10
–5
M). The results showed that for all 
compounds the highest values occurred in the acid range, being superior to those 
obtained in distillate water. However, as it was expected,
21
 in the basic range there was 
a significant decrease in the relative fluorescent quantum yields, being these probes 
inadequate for labelling applications at pH 12. The observed variations can be 
influenced by the H-aggregation (detected in the absorption spectra), which is more 
effective at basic pH, resulting in lowest ΦF values.
22
 
 
< Figure 3> 
 
 
Conclusion 
 
In this work, bifunctionalised benzo[a]phenoxazinium dyes, possessing ester, hydroxyl 
and the chlorine atom as terminals in position 2, in addition to the amine group terminal 
in 9-position of the polycyclic system were obtained. 
 7 
These cationic fluorophores, with absorption in ethanol, in physiologically simulated 
conditions and distilled water in the 610-620 nm range, were highly fluorescent and 
displayed a maximum emission wavelength between 642 and 651 nm. 3-Amino-N-(2-
(4-ethoxy-4-oxobutoxy)-5-(propylamino)-9H-benzo[a]phenoxazin-9-ylidene)propan-1-
aminium chloride 4b was used in the covalent labelling of valine, as a simple model of 
biomolecules, resulting in the corresponding bioconjugate with superior wavelengths of 
absorption and emission maxima regarding label 4b and high fluorescence.  
The preliminary results obtained in the present work suggest that the new 3-amino-N-
(2-(un)functionalised-5-(propylamino)-9H-benzo[a]phenoxazin-9-ylidene)propan-1-
aminium chlorides are interesting candidates for further studies in the  labelling  of 
biomolecules, being the most effective fluorescence associated to aqueous buffer 
solutions in the acidic pH range. 
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33. Procedure for the preparation of 3-(2-((tert-butoxycarbonyl)amino)-3-
methylbutanamido)-N-(2-(4-ethoxy-4-oxobutoxy)-5-(propylamino)-9H-
benzo[a]phenoxazin-9-ylidene)propan-1-aminium chloride 5: To a solution of N-tert-
butyloxycarbonyl valine (8.42×10
-3
 g, 3.87×10
-5
 mol) in dry DMF (0.5 mL) at 0 ºC, 1-
hydroxybenzotriazole (5.24×10
-3
 g, 3.87×10
-5
 mol) and triethylamine  (6.45×10
-3
 mL, 
4.65×10
-5
 mol) were added, followed by N,N’-dicyclohexylcarbodiimide (8.40×10-3 g, 
4.07×10
-5
 mol) after stirring 10 minutes. After 10 minutes 3-amino-N-(2-(4-ethoxy-4-
oxobutoxy)-5-(propylamino)-9H-benzo[a]phenoxazin-9-ylidene)propan-1-aminium 
chloride 4b (2.45×10
-2
 g, 4.65×10
-5
 mol) was added and the reaction mixture was stirred 
at room temperature during four days. The solvent was evaporated and the crude residue 
purified by column chromatography using dichloromethane/methanol, mixtures of 
increasing polarity, as the eluent, to give compound 5 as a blue solid (0.015 g, 43%).  
Mp. 90.0-91.4 ºC. Rf = 0.84 (dichloromethane/methanol 8:2). FTIR (KBr 1%): max 
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3359, 2967, 2932, 1702, 1645, 1592, 1548, 1494, 1463, 1421, 1390, 1366, 1302, 1258, 
1163, 1129, 1102, 1041, 910, 821, 746.
NMR (CD3OD, 400 MHz):  0.80-1.10 (6H, 
m, -CH3 Val), 1.11 (3H, t, J = 6.8 Hz, NHCH2CH2CH3), 1.28 (3H, t, J = 7.2 Hz, 
CO2CH2CH3), 1.47 (9H, s, C(CH3)3), 1.80-2.0 (4H, m, NHCH2CH2CH3 and 
NHCH2CH2CH2NH), 2.10-2.12 (1H, m, -CH Val), 2.13-2.25 (2H, m, 
OCH2CH2CH2CO2CH2CH3), 2.60 (2H, t, J = 7.2 Hz, NHCH2CH2CH2NH), 3.35-3.45 
(4H, m, NHCH2CH2CH3 and OCH2CH2CH2CO2CH2CH3), 3.55-3.72 (2H, m, 
NHCH2CH2CH2NH), 3.80-3.92 (2H, m, -CH Val), 4.10-4.30 (4H, m, 
OCH2CH2CH2CO2CH2CH3 and CO2CH2CH3), 6.66 (1H, broad s, H-6), 6.73 (1H, broad 
s, H-8), 7.02 (1H, t, J = 8.0 Hz, H-3), 7.23-7.33 (2H, m, H-10 and H-11), 8.07 (1H, 
broad s, H-4), 8.18 (1H, s, H-1). 
13
C NMR (CD3OD, 100.6 MHz): δ 11.78 
(NHCH2CH2CH3), 14.61 (CO2CH2CH3), 18.70 (-CH3 Val), 23.21 (NHCH2CH2CH3), 
25.67 (NHCH2CH2CH2NH), 28.77 (OCH2CH2CH2CO2CH2CH3), 28.84 (C(CH3)3), 
31.56 (-CH Val), 37.85 (NHCH2CH2CH2NH and OCH2CH2CH2CO2CH2CH3), 42.12 
(NHCH2CH2CH3 and NHCH2CH2CH2NH), 61.70 (CO2CH2CH3), 62.18 (-CH Val), 
68.78 (OCH2CH2CH2CO2CH2CH3), 80.61 (C(CH3)3), 93.47 (C-6 and C-8), 107.56 (C-
4), 118.24 (C-3), 126.03 (C-1), 128.18 (C-Ar), 129.57 (C-Ar), 133.88 (C-11, C-Ar), 
134.90 (C-10 and C-Ar), 142.91 (C-Ar), 153.23 (C-Ar), 157.74 (OCONH), 158.06 (C-
9), 159.19 (C-5), 163.11 (C-2), 165.26 (CONH), 174.87 (CO2CH2CH3). HRMS: m/z 
(ESI): calcd. for C35H48N5O5 [M
++1] 618.36500; found 618.36359. 
34. Perrin, D. D.; Dempsey, B. Buffers for pH and metal ion control, Chapman and 
Hall, Londres, 1974. 
35. Sens, R.; Drexhage, K. H. J. Luminesc. 1981, 24, 709-712. 
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CAPTIONS 
 
Table 1 – Absorbance and fluorescence data in ethanol, physiological pH and 
distilled water for compounds 4a-d and 5. 
 
Figure 1 – Normalised absorbance spectra of compounds 4a-c and 5 measured in 
ethanol (C = 6.67×10
-6
 – 3.00×10-5 M). 
 
Figure 2 – Normalised absorbance spectra of compounds 4a-c and 5 measured at 
physiological pH (C = 6.67×10
-6
 – 3.00×10-5 M). 
 
Figure 3 – Normalised fluorescence spectra of compounds 4b and 5 measured in 
ethanol and at physiological pH (C = 6.67×10
-6
 – 3.00×10-5 M). 
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TABLES 
 
 
Table  1.  
Cpd 
Ethanol pH 7.4 Water 
abs 
(nm) 
λem 
(nm) 
ΦF 
Δ 
(nm) 
abs 
(nm) 
λem 
(nm) 
ΦF 
Δ 
(nm) 
abs 
(nm) 
λem 
(nm) 
ΦF 
Δ 
(nm) 
4a 613 641 0.43 28 613 651 0.28 38 613 647 0.31 34 
4b 620 642 0.60 22 612 646 0.26 34 610 644 0.64 34 
4c 616 643 0.60 27 616 644 0.63 28 614 646 0.88 32 
4d 617 643 0.32 26 614 648 0.27 34 615 648 0.65 33 
5 625 645 0.54 20 616 650 0.28 34 618 651 0.54 33 
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SCHEMES 
 
Scheme 1 
 
 
 
 
 
 
